×

The transition from hospital to primary care for patients with acute coronary syndrome: insights from registry data

In Australia, acute coronary syndrome (ACS) accounts for about 75 000 hospital separations annually, and in 2010 cost more than $8 billion.1 Those who survive are at high risk of recurrent events; in 2010, more than 25 000 Australian hospital separations were associated with repeat ACS2,3 at a cost of more than $600 million (direct costs only).1 Between 2000–01 and 2008–09, the largest expenditure increase, by health care sector, was for hospital-admitted patient services, where cardiovascular disease expenditure increased by 55%, from $2907 million to $4518 million.4 A recent report projected that by 2020 there will be around 102 363 separations associated with ACS in Australia, and about half of these will be due to repeat events.1 These statistics highlight the growing importance of secondary prevention as more people survive initial events. Further, it underscores the need for a health system that has an inbuilt process for commencing prevention during acute admissions, and the need to ensure an effective transition from hospital to primary care.

Favourable modification of coronary risk factors is responsible for at least a 50% reduction in mortality from cardiovascular disease.5,6 Further, participation in secondary prevention programs leads to improved clinical, behavioural and health service outcomes, including fewer hospital readmissions, better adherence to pharmacotherapy, enhanced functional status, improved risk profile, less depression, and better quality of life.79 However, only a minority participate,10 systematic follow-up is fragmented,11 and questions remain about how well the health system facilitates transition from hospital to primary care. Overall, with ACS dominating expenditure and gaps in secondary prevention widely documented, addressing the delivery of care at the point of hospital discharge is a priority.

Modern cardiology has seen significant advancements in diagnosis, revascularisation, pharmacotherapy and overall more successful treatment of acute illness.12 This ultimately means that more people are surviving their initial ACS event and are having shorter hospital stays, which has resulted in more people returning to the community and resuming their everyday lives.13 However, one-quarter of survivors will be readmitted to hospital within 1 year of the index event, and a significant number of readmissions will end in death.2,3 Consequently, the demand for effective, continuing post-hospital preventive care is intensifying; the foundations of this are built during the acute episode.14

The purpose of this article is to provide insights from registries, and their implications for secondary prevention in Australia.

Gaps in secondary prevention: data from Australian ACS registries

Three large-scale Australian ACS registries — namely, SNAPSHOT ACS, the Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE) and the Acute Coronary Syndrome Prospective Audit (ACACIA) registry — have provided contemporary data about secondary prevention and resource gaps.

The SNAPSHOT ACS audit provides recent data pertaining to pre- and inhospital ACS care in Australia and New Zealand.12 The audit involved the collection of detailed information about 4398 consecutive patients admitted to 483 public and private hospitals across the two countries over 2 weeks in May 2012.12 The ACACIA registry enrolled 3402 ACS patients from 39 hospitals across Australia (25% rural, 75% metropolitan).3 CONCORDANCE is an ongoing (prospective) clinical initiative that provides continuous real-time reporting on the clinical characteristics, management and outcomes of hospitalised ACS patients to clinicians, hospital administrators, sponsors, interested stakeholders and government.15 CONCORDANCE currently includes about 5200 patients from more than 40 hospitals.

As a group, the Australian ACS registries provide detailed and contemporary information about inhospital care. All three registries show suboptimal rates of pharmacotherapy and cardiac rehabilitation referral. The proportion of patients prescribed at least four of the five indicated pharmacotherapies at discharge was 68% in CONCORDANCE16 and 65% in SNAPSHOT ACS.12 In terms of cardiac rehabilitation, 58% were referred in CONCORDANCE17 and 46% in SNAPSHOT ACS.12

A recent article resulting from SNAPSHOT ACS reported that only 27% (628/2299) of Australian and New Zealand patients admitted to hospital for ACS received a combination of guideline-recommended medications, referral to rehabilitation and basic lifestyle advice before hospital discharge.11 The authors suggested that a greater focus on inhospital delivery of preventive care is needed to provide the essential foundation for lifelong secondary prevention.11

However, it should also be noted that registries have limitations, such as the reliance on inhospital documentation, and they may not be able to determine individual contraindications.

The challenges in implementation of secondary prevention

There are well known limitations in the implementation of secondary prevention after ACS. Despite proven effectiveness and clear recommendations in best-practice guidelines,18 there is poor use of effective medications, cardiac rehabilitation and adherence to lifestyle recommendations.19 In the recent AusHEART survey of more than 5000 Australian general practice patients, 1548 had clinically expressed cardiovascular disease, and only half of these were following recommended treatments.20 Valid national data on participation in cardiac rehabilitation and exercise therapy are not available, but estimates from local and international reports indicate that less than 30% of eligible patients participate in such programs.10,21 Compliance with lifestyle change is no better. It was recently reported that among 18 809 patients from 41 countries who had experienced ACS, only 30% of patients adhered to diet and exercise recommendations, and about two-thirds of smokers had quit smoking 6 months after their event.22

Overall, it is difficult for a coherent strategy to emerge when the volume of evidence describing and reporting disparate models of delivery continues to expand.13 In reality, about 70% of Australian secondary prevention programs continue to follow the traditional cardiac rehabilitation model of structured and group-based exercise with education sessions.19 These programs are associated with well documented barriers, including the need for transport, poor health provider support, limited time frames and minimal individualisation. Thus, policymakers, health professionals and researchers are confronted by the need for increased services to improve access and equity, but often with significant challenges coupled with finite and declining resources.13

Opportunities for improved access to and uptake of secondary prevention

A recent blueprint for reform summarises the outcomes of a national summit that aimed to improve implementation of secondary prevention in Australia.23 The report identifies stakeholder consensus for an approach where each patient’s acute episode of care, particularly at discharge and follow-up, is patient-centred. The report also highlights the current challenges associated with the existence of a divide between hospital and general practice care. That divide is apparent in terms of a definition of prevention and rehabilitation, patient communication, service provision, funding and data collection. The summit report also summarises opportunities for improved implementation of secondary prevention.23 Although not exhaustive, the published opportunities present practical suggestions that cover a range of issues, including public health support, better coordination and use of existing strategies, workforce, quality assurance and technology, as follows:

  • Increased delivery of comprehensive secondary prevention in primary care
    • Provision of connected care through a case-management approach, improved communication, and greater provider education relating to secondary prevention, behaviour change techniques and self-management strategies.
    • This model of care should be coupled with specific incentive programs similar to those already available for diabetes and asthma management.
    • Possible development of a role for cardiac care coordinators, who would ideally be recognised by Medicare. These coordinators could collaborate with the person with ACS and other members of the care team to achieve mutually agreed clinical targets, good health and wellbeing.
  • Increased focus on and awareness of the need for lifelong secondary prevention
    • Potential for widespread media and public awareness campaigns to raise the profile and understanding of ACS as a chronic condition requiring lifelong management.
    • Requires linking with and engagement of state and federal governments, Medicare Locals, consumers and private health funds to facilitate sustainability.
  • Better integration and use of existing services
    • Better use of existing initiatives, such as cardiac rehabilitation, chronic disease management plans, private health insurance programs, and other initiatives including the Home Medicines Review, Heart Foundation programs (eg, Heartmoves) and Quitline.
    • Better use and awareness of these existing programs may require development of a comprehensive inventory, database or website, and could be the domain of a national preventive agency, ideally in collaboration with state governments, Medicare Locals and non-government organisations, but could otherwise be housed by an established non-government organisation such as the National Heart Foundation.
  • Data monitoring and quality assurance
    • Identification of performance measures to enable cross-national comparison is needed for post-hospital care. This should incorporate measures of service delivery as well as health outcomes, including hospital readmissions and coronary heart disease deaths.
    • This could occur via an online registry and/or electronic medical records and data linkage.
  • Embracing new technologies
    • New technological developments have seen a rapid rise in devices and trials aimed at managing cardiovascular disease risk factors, medication adherence and providing coordinated care.
    • Ongoing development and testing of technological advances may facilitate greater access to secondary prevention.
    • Examples of e-health approaches include the use of text messaging, telephone-delivered care, development of websites and smartphone apps and remote monitoring and remote delivery of programs.

The increasing role of primary care in ACS management

ACS requires lifelong management, and primary care is ideally positioned to provide this care to patients.23 There is a need to go beyond giving patients a discharge summary and advising them to make an appointment. In one study, about 20% of patients did not have a discharge summary forwarded to their general practitioner, and 68% of GPs rated the information in the summaries they received as “very good” to “excellent”.24

In Australia, there has been a substantial shift in the payment system for GPs towards incentives that encourage evidence-based care of patients with chronic diseases in line with a disease management framework that emphasises systematic, coordinated care and self-management. The Australian Government’s commitment to a National Primary Health Care Strategic Framework provides an opportunity to establish primary care systems and funding models to enable people who are at high risk of a cardiovascular event to be identified early for preventive care.25 The National Heart Foundation maintains that a well developed primary care framework for secondary prevention will increase referral and access rates to secondary prevention services, enhance continuity of care and improve coordination of services between hospitals and the community.26

Conclusion

Despite guideline advocacy, uptake of proven secondary prevention strategies for heart disease is suboptimal. Australian registries provide contemporary data that reinforce the evidence–practice gaps in secondary prevention. Trial and cohort data highlight the need to commence prevention early if we are to narrow the divide between hospital and the community, thereby achieving better individual, provider and system-level outcomes. Patients often leave hospital without systematic follow-up and with an unclear picture of how and if they will be managed and supported on the next phase of their chronic disease journey. Potential opportunities to bridge the divide include development of an incentive scheme in primary care, development of a cardiac care coordinator role to work in concert with treating doctors and patients, better use of existing services, effective data monitoring and embracing new technologies.

Adherence to secondary prevention therapies in acute coronary syndrome

“Drugs don’t work in patients who don’t take them.” — C Everett Koop

Despite the overwhelming evidence of the effectiveness of secondary prevention therapies,1,2 surveys locally and overseas indicate poor uptake of medical treatments and lifestyle recommendations after an acute coronary syndrome (ACS),3,4 and a concerning lack of recognition of this problem by clinicians.35 In one cross-sectional survey of Australian general practices, only about a half of patients with known coronary heart disease were taking recommended treatments.5 This is similar to findings from other high-income countries, and the situation is much worse in low- and middle-income countries.6 Adherence to lifestyle recommendations is also poor, with only about a third of patients adherent to lifestyle recommendations on diet, exercise and smoking 6 months after their ACS.7

The World Health Organization defines adherence as “the extent to which a person’s behaviour — taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”.8 The terms compliance and adherence are conceptually similar. However, an important difference is that adherence better reflects active involvement of the patient and a therapeutic alliance with the physician, whereas compliance implies passive patient obedience.9,10 Poor adherence may be conscious or unconscious, and includes patients missing doses, missing days, taking drug “holidays”, and forgetting to renew their prescriptions. Adherence also encompasses persistence — the continued taking of medications for the intended course of therapy.

Poor adherence results from complex interplay of multiple factors (Box 1). At the individual level, this ranges from physical disability and mental health to patients’ perceptions of their illness, health literacy and social context.11 Physicians contribute to the problem by prescribing complex therapies, failing to identify non-adherence and failing to identify side effects. There is growing evidence that many trials underestimate the severity of side effects.12,13 Also, clinicians may fail to recognise non-adherence in as many as half of their patients identified as non-adherent based on pharmacy claims data.14

While an ACS event would be expected to motivate a person to change behaviour, patients stop taking their medications as early as a few weeks after discharge, and non-adherence rates increase with time.15,16 According to one study of 1521 patients with acute myocardial infarction (AMI), at 1 month after AMI, 18% reported discontinuing at least one of the three major drug classes (aspirin, β-blocker or statin).15

Not surprisingly, poor adherence is associated with worse outcomes. In one population-based longitudinal observational study of more than 30 000 AMI survivors, poor adherence to statins in the first year after AMI was associated with a 25% higher risk of mortality.17 Premature discontinuation of thienopyridines (eg, clopidogrel) within a month after an AMI treated with drug-eluting stents was associated with increased mortality during the next 11 months (7.5% v 0.7%; P < 0.001) and increased hospitalisation (23% v 14%; hazard ratio, 1.5).18 Similarly, among patients with stable coronary disease, non-adherence to angiotensin-converting enzyme (ACE) inhibitors, β-blockers and/or statins, identified in 25% of patients, were each associated with an increased relative risk of cardiovascular re-admissions (range, 10%–40%), coronary interventions (range, 10%–30%) and cardiovascular mortality (range, 50%–80%).19 Good adherence is associated with improved outcomes. In analyses of the CRUSADE ACS registry, every 10% increase in the overall composite guideline adherence was associated with a 10% decrease in the likelihood of inhospital mortality.20 Better outcomes with adherence may be due to a “healthy adherer” effect. In clinical trials, even patients more adherent to placebo have better outcomes.7,21

Detection of non-adherence

Measuring non-adherence is challenging. Even in the research setting, there is no gold standard tool. For some types of drugs, a direct technique can be applied; for example, measuring levels of the drug or its metabolite in blood or urine, or the effect of the drug on a known biochemical measure (eg, cholesterol levels). Other methods used in trials include pharmacy refill records and pill counts, but these do not account for “pill dumping” and pattern of intake (erratic timing). Several clinical trials use the MEMS (Medication Event Monitoring System), which is a microprocessor attached to a bottle to record the occurrence and timing of bottle opening. However, even this cannot assess whether the patient actually takes the drug once the bottle is opened. While there is potential bias associated with misreporting and self-report, standardised questionnaires remain important tools to quantify non-adherence (Box 2).25,26

Interventions to improve medical adherence

Several interventions that target the modifiable factors that influence adherence have been explored (Box 3). Systematic reviews have examined improving medical adherence among chronic disease patients and identified a diverse range of interventions, including many that are complex. However, they have struggled with classifying interventions and thus pooling them to enable a comparison of their efficacy.27

There is very little research that directly trials interventions that improve medical adherence to secondary prevention drugs among patients with coronary heart disease. Secondary prevention programs, including cardiac rehabilitation programs, often include modules that focus on supporting lifestyle modification, risk factor management and medical adherence.28,29 The intensity of these programs ranges from face-to-face involvement in inhospital programs and telephone counselling30 to — more recently — text message reminder systems.31 With regards to specific drugs, there has been examination of interventions to improve adherence to lipid-lowering drugs and hypertension medications in broader populations.32 The more recent of these, with respect to lipid-lowering drugs, identified 11 studies and concluded that patient re-enforcement and reminding was the most promising category of interventions — it was investigated in six trials, of which four showed improved adherence, with an absolute increase in adherence ranging from 6% to 24%.32

Another type of intervention that has been explored more recently involves simplifying the regimen by using fixed-dose combination medication. The UMPIRE study examined the impact of a fixed-dose combination (a four-drug combination of aspirin, ACE inhibitor, statin, and either a β-blocker or a thiazide) in 2000 patients. The self-reported adherence in the intervention arm (polypill) at median 15-month follow-up was significantly higher (86% v 65%; relative risk of being adherent, 1.33; 95% CI, 1.26–1.41; P < 0.001). The effect size was most marked among patients with poor baseline adherence.33

What can a physician do?

While there is increasing research interest in drug adherence, comprehensive data are not yet available. There is little literature on the comparative efficacy of interventions and, as such, there is no clear best way of achieving improved medical adherence. Also, it is unlikely that there will be a “one-size-fits-all” solution for all patients.34

From a practical viewpoint, some suggested approaches are described here. Screening for medical adherence can be done simply and should be done at every patient consultation. The most practical approach is to have a high index of suspicion, and to interview patients in a non-judgemental manner. The discussion can be initiated with a neutral question, for example:

  • “What do you think about taking these medications daily?”
  • “How often do you miss taking them?”

Patients should also be asked about the cost of therapy and its affordability. It may also be important to ask about missed doses over longer periods (eg, the past month), to avoid the potential for “white-coat adherence” — a transient improvement in adherence for a few days before and after health personnel contact. A potential approach to questioning patients on adherence from the National Heart Foundation is summarised in Box 4. The American College of Preventive Medicine has also identified an approach that can be categorised under the mnemonic SIMPLE (Box 5).36

Conclusion

Non-adherence is a serious problem and a particularly important issue for patients with chronic disease requiring multiple medications. Low adherence is associated with increasing morbidity, mortality and increased costs of health care. Already, several innovative and effective strategies exist to improve adherence. Our standard of care needs to include identifying whether non-adherence exists, what individual factors are influencing it and what interventions may minimise non-adherence.

1 Examples of factors that may reduce adherence to therapy

Patient

  • Physical impairment (impaired dexterity, poor vision)
  • Cognitive impairment
  • Psychological (depression)
  • Language barriers (non-English speaking)
  • Health literacy
  • Comorbidities

Health system

  • Poor patient–provider relationship
  • Health professionals’ lack of time and lack of incentives
  • Poor continuity of care (hospital–community care transition)
  • Geographic location and access to services, pharmacies and transport

Therapy

  • Complex regimen (multiple dosing during the day)
  • Complex dose (frequent titrations or substitution)
  • Polypharmacy
  • Side effects

Socioeconomic

  • Income
  • Low levels of patient education and/or literacy
  • Poor social support (single status)
  • Unstable living conditions (homeless, frequent travel, shift workers)

2 Self-report questionnaires to assess medication non-adherence

Questionnaire

Components

Features


BMQ22

Three sets of questions:

  • Five-item “regimen screen”
  • Two-item “recall screen”
  • Two-item “belief screen”

Validated against MEMS

MARS-523

Modified from MARS-10

Five-point Likert scale

First question: unintentional non-adherence

Other four statements: intentional non-adherence

Variable sensitivity reported in studies (when matched with pharmacy refill data)

MMAS24

Two versions:

  • MMAS-4 (original)
  • MMAS-8 (2008 modification)

Brief; ease of dichotomous response


BMQ = Brief Medication Questionnaire. MARS = Medication Adherence Rating Scale. MMAS = Morisky Medication Adherence Scale. MEMS = Medication Event Monitoring System.

3 Modifiable factors influencing adherence and persistence and examples of interventions

Modifiable factor

Intervention


Regimen complexity

Simpler, less frequent dosing regimen

Cost of therapy

Prescription of generic medications

Pill burden

Combination polypill

Improved tolerability

Selection of medication with low side-effect profile

Patient acceptance of disease

Health literacy and counselling

Patient trust in therapy

Patient–prescriber–pharmacist relationship

Forgetfulness

Reminders

4 Questions to ask patients to assess their adherence to medicines35

To assess medicine-taking behaviour

  • How are you going with those tablets?
  • How have you been taking these medicines?

To assess beliefs and attitudes

  • How do you feel about taking these medicines?
  • Have you ever thought about changing your medicines?
  • How well does this medicine work for you?

To assess both

  • It must be hard trying to remember to take the tablets every time. Do you ever forget? How do you feel about that?
  • People often have difficulty taking their pills, and I am interested in finding out any problems that occur so that I can understand them better. Do you ever miss taking your medicines? How often?
  • When you feel better, do you sometimes stop taking your medicine?

5 SIMPLE approach to enhance adherence36

S

Simplify the regimen

  • Adjust timing, frequency and number of tablets to suit patient
  • Attempt to change the situation, not the patient
  • Encourage use of adherence aids (eg, mobile app reminders)

I

Impart knowledge

  • Focus on patient–provider shared decision making
  • Provide written and verbal instructions
  • Simple language and 3–4 major points
  • Encourage involvement of nurse and pharmacist

M

Modify patient beliefs and human behaviour

  • Empower patient to self-manage the condition
  • Ensure patient understands the risk of not taking the medication
  • Address fears and concerns of patient

P

Provide communication and trust

  • Clear communication from provider
  • Build safe environment where patient feels comfortable
  • Informed and shared decision making

L

Leave bias

  • Self-learning exercise in area and incorporating into practice
  • Use of culturally and linguistically appropriate interventions
  • Tailor education to patient’s level of understanding

E

Evaluate adherence

  • Periodic review
  • Self-report and medication adherence scales
  • Biochemical tests — definitive confirmation

The medical workforce of the future

This is a republished version of an article previously published in MJA Open

Doctors training now will have a very different world of practice. They will need to understand team care, patient engagement in decision making and clinician leadership as well as the rapidly changing health system. But what an exciting environment to be entering, with all the advances in care available and expanding into the future — as long as we can afford them.

This issue of MJA Open is about the role that doctors will play in the health system of the future, where and how they might work, how we might train them and how are we going to fund them.

The health and social welfare sector is now the largest workforce in Australia (1.4 million), not to mention the 2.3 million carers (both paid and unpaid) who provide support every day for those Australians who for many reasons cannot take care of themselves. This workforce is, like the rest of the population, ageing and wanting to work in different ways. What we can do for patients has changed so much over the past 20 years that it often bears little relation to what health professionals were taught at university — and this change is likely to continue into the future at an even more rapid pace. The importance of the health workforce is no better emphasised than by the Australian federal and state governments’ commitment to establish Health Workforce Australia in 2009 with triennial funding of $1.4 billion. This organisation has as its mission creating a more sustainable health workforce by 2025 (https://www.hwa.gov.au).

New knowledge and technology are great drivers of change in medicine, as in other disciplines. The increase in genetic testing in the past 10 years alone has been responsible for a major shift in diagnosis, treatment and prevention of many diseases. New imaging techniques have allowed diagnosis of conditions at a much earlier and often more easily treatable stage, such that diseases that killed 30 years ago (many forms of cancer, some metabolic disorders) are now curable, or patients can maintain a good quality of life with continuing therapy. There is little doubt it will be chronic diseases and dementia that will shape the challenge of delivering health services in the foreseeable future.1

These and other developments have prompted much discussion and review within the medical and broader health professions, in the community, and particularly within medical schools, where we are preparing young people for careers that will run for 40 or more years. One of the major challenges for educators and health professionals is accepting that health care is now delivered as a team activity by various health professionals; and one of the most important issues for health professional education is embedding those team care skills through various interprofessional learning experiences.2 That said, given the pivotal role that doctors play in health care, this MJA Open will concentrate on the role that doctors play in the health workforce.

The questions we face as we develop curricula, prepare exams, run tutorials and teach clinical skills are complex. It is easy enough to say that change will occur, but narrowing down the specifics of what and where — and preparing for such a future — provides a challenge of a different magnitude altogether. For example, how will we cope with clinical training demands from the increasing number of medical students, when patients in hospitals are now often unable to be as involved in teaching programs as they were a decade or two ago, because of the nature of their condition or the short period of their stay in hospital? What are the opportunities for clinical learning in private hospitals, in aged care and mental health facilities and in primary care? How can we effectively use the wonderful clinical experiences that abound outside the traditional tertiary teaching hospitals in primary care, aged care facilities, mental health services and in the community? All medical schools have embraced the need to increase clinical training opportunities to some extent through rural clinical school initiatives, by which students spend the bulk of their clinical training in the rural sector and achieve equivalent examination results to those trained in city hospitals. It should be acknowledged, however, that some schools have done better than others in this regard.3

So how different do we believe the practice of medicine will really be in the future? What tasks will doctors still need to do? What will patients want from us? How much of our daily routine will be performed by other health professionals? What role will IT (information technology) play in practice? Will consultations all take place remotely? Certainly, telemedicine is changing the way we deliver health services, but it has taken us over a decade from the emergence of data showing that it could work to reach the point where we actually have an item number allowing doctors to charge for this service.

More fundamentally, can we anticipate what changes are likely and prepare students accordingly? And how much of our focus should be on developing the skills to learn, to discover, to evaluate new knowledge as it becomes available and to understand change management? In this rapidly changing environment, perhaps we need to revisit our fairly recent focus on specialism and train more generalist health professionals who have greater flexibility to change career track as the environment around them changes.

Much may not change

A fundamental interaction between patient and doctor is the consultation or the procedure, and this may change little. Doctors have been taking histories and examining people for millennia. The nuances of communication and the time-honoured physical examination skills will still require personal contact between patient and provider, although significant amounts of this interaction may develop a “virtuality”. The task of gathering and evaluating data through patient history-taking, physical examination and diagnostic testing to form a differential diagnosis, which is then tested and challenged until the diagnosis is confirmed, will not change. It will, however, be significantly enhanced by such things as an electronic health record owned by the patient and shared between professionals. This will surely rid us of much duplication of effort as patients move across the health system.

Some consultations may take place virtually, particularly among patients with chronic disease who need following up and people living in distant locations. It is also possible for people with diabetes to have their weight, exercise, blood glucose and HbA1c all monitored via a mobile phone, and for communication with the doctor or other health professional to take place by phone or as a telehealth consultation. As health professionals, we often do not appreciate the time taken for both patients and professionals to travel between appointments. Yet, there is a need to quickly explore and evaluate such new models of health care delivery.

The attributes we look for in admitting students to our medical program — compassion, understanding, empathy, a sense of ethics — and the skills of problem solving, listening and communication will be critical in health professionals far into the future.4 Advances in biology and IT will never overshadow them.

Other aspects of medical practice, similarly, will change little over the next decades. Most of the sickest patients will continue to be treated in hospital, where doctors will increasingly be focused on resolving acute exacerbation of chronic health issues, treating life-threatening conditions such as cancer and managing severe trauma. Most of the medical profession’s work will continue to occur in community settings, whether in general or specialist practice, but there will be a need to shift our focus to out-of-hospital care models, as well as to get serious about disease prevention.5

Predictions even a decade ahead in a field such as medical workforce necessarily involve qualification. Having said that, we can be reasonably confident that the recent drivers of change — which have already altered the practice of medicine to varying degrees — will continue to be a factor into the foreseeable future. They will challenge experienced practitioners and young graduates alike. Issues such as the feminisation of the workforce, work–life balance, and safe hours clauses have had significant influences on training and on how we manage the workforce. Should we continue to rely on overseas-trained doctors, from countries who often need them much more than we do, to support our workforce — particularly in rural areas? The rapidly increasing costs of health care will also play a major role in stimulating new ways of approaching health care delivery. An uncapped fee-for-service system that encourages activity rather than rational care is unlikely to escape the eye of government funding circles for very much longer.

More than anything else, the way doctors operate in the future will be influenced by advances in IT, biology, pathology and therapy.

Every year, we will have new graphic insights into anatomical nooks and crannies and physiological or pathological functions in molecules that at the moment we may not even know exist. Tracking of metastatic cells, visualisation of oxygen-starved tissues and toxin-poisoned cells will be routine. Tumours will be phenotyped in far greater detail than at present. Patterns of expression of proteins in cancers and detection of minute quantities of these proteins in blood will change diagnosis, prognostication and our ability to tailor treatments to individual patients and their tumours. Drug sensitivities, toxicities and methods of administration will be refined. The therapeutic armamentarium will be expanded to include inhibitors and modifications of molecules yet to be identified. We may not yet have a complete understanding of the interaction between all the proteins expressed by our 25 000 genes or between each of the two copies of our genes, but we will know our basic gene sequence. Advances in stem-cell therapies, bioengineering and nanotechnology will provide exciting opportunities both diagnostically and therapeutically.

But if advances in biology and improvements in pathology and imaging give us the potential for faster and more accurate diagnoses of diseases, doctors will be required to upgrade their skills or learn new skills.

More than ever before, they will need to be able to sort the wood from the trees. Collecting, critiquing, and interpreting the vast amounts of new information will be an increasingly important skill of future practitioners. Doctors will need high-order abilities in data management. Much of the information will be biological, so doctors will also need a thorough understanding of what is normal to recognise what is not so normal.

Research training, by which students and graduates become experienced in critical thinking and interpretation of new knowledge as it becomes available, will become increasingly important. There will be a need to encourage interdisciplinary research, encompassing engineering nanotechnology and IT, and to look for ways of appropriately funding this research. There is also a need for research on educational methods such as simulation, on health systems research and on how to implement new knowledge.

In all this, the roles of patient and doctor are likely to change. Doctors will not be the all-authoritative figure but part of, or the leader of, a team of professionals providing a range of care in an integrated, evidenced-based way. Leadership skills will be required by some and “followership” skills by all.

The challenge of managing resources

Managing health resources in an era of longer lives, high technology, increased expectations and rising incidence of chronic disease will be one of the key challenges for governments, communities and the medical profession.

In the decades ahead, resource allocation will need to change from acute care to preventive care. The changes will need to be supported by evidence, and will need to result in greater resources for prevention. Vaccinating young women and men against papilloma virus, for example, will save many lives and much morbidity and reduce the high cost of treating cervical cancer.

Resource allocation will be guided by engaged community discussions on subjects such as the need for advance health care directives, issues surrounding the right of access to high technology, high-cost end-of-life care, allocation of resources to people with disability, consumers’ responsibility for self-care, and roles and responsibilities of families in providing care. Ideally, resource allocation will be without political or professional self-interest, and will balance the best interests of the individual against those of the population.

Doctors will need to be fully involved in critical decisions on resource allocation, but to fully participate they will need to be informed by research and able to take responsibility for the active enquiry which informs policies and decisions.

Doctors should be the key advocates for our health system and our patients. Hopefully, by 2025, we will have long moved on from the current cost-shifting between state and federal governments; but the risk of bureaucratic armies or ill informed decisions that result in funds being diverted to meet political or other objectives rather than spent on health care will always be there.

Changing populations and diseases

It is almost certain that patients, even a decade ahead, will be different. Immigration patterns are already changing Australia’s population, and medicine is increasingly a profession where people have the opportunity to (and do) work in all corners of the globe.

Disease patterns will likely be different. If the global epidemic of obesity is unchecked, people with diabetes, blindness, renal failure, stroke, myocardial and peripheral ischaemia and arthritis will overwhelm our hospitals. Infectious diseases will change if global warming continues; dengue and many other arthropod-borne diseases will occur in temperate climates. People will be more mobile, and diseases seen infrequently in Australia will likely become more prevalent.

Doctors of the future will need to have a broad understanding of the scope of medical practice in Australia and internationally. Their training and experience will have given them experience in the public and private health systems, and in metropolitan and rural and remote Australia.

Understanding of the needs of patients in these different settings and areas will enable better allocation of resources and the provision of better care. This is more a wish than a prediction, but we believe that if all doctors spend a period of time — either during medical school training or after — in a resource-poor health care setting in a developing country, it would provide them with insight and experience of advanced pathology and the scale of international suffering and health inequity.

The future?

As educators, our role is to try to anticipate these changes and prepare our graduates with the skills to drive change and thrive on uncertainty. These skills include not only research training and lifelong learning, but the management and leadership skills to predict and forge the changes that will inevitably occur in their own practising lives.

For this MJA Open, we have asked authors to be provocative and challenge the status quo and to project their area of expertise into the future and see how the medical workforce will sit within the health system in 2025. This must be from the perspective of how we fund health care, who will be working in it, international migration of health workers, and how we get doctors to work in rural areas and with disadvantaged populations. We are sure there are areas we have not covered, but we hope this publication will stimulate your contributions to medical workforce solutions.

Playing it safe

This issue sees the launch of a new series on diabetes that will span several upcoming issues of the Journal. In his introductory editorial, diabetes series guest editor Colagiuri (doi: 10.5694/mja14.01307) outlines key aspects that will be featured, highlighting an evidence–practice gap that is contributing to the burden of this condition in Australia.

In this issue, we also focus on patient safety. Hillman and colleagues (doi: 10.5694/mja14.01088) discuss the evolution of hospital rapid response systems, which are usually triggered by predefined deviations in patients’ vital signs. They suggest that system-wide engagement is likely to be critical to the success of such systems in improving patient outcomes.

New research from the Concord Medical Emergency Team (MET) Incidents Study (doi: 10.5694/mja14.00647) suggests that the disruption caused by staff leaving normal duties to attend MET calls did not result in major harm to other patients. In their single-centre study, MET call participants were interviewed to ascertain the rate of adverse events and incidents related to their diversion to cover MET calls. After 2663 MET call attendances, participants reported no adverse events and an incident rate of 213.7 per 1000 MET participant attendances, all of which were classified as “minor” or “minimum”. Although it is unclear if these findings can be extrapolated to other centres, they certainly provide some reassurance.

While patient safety is clearly top of mind, what about that of health care workers? Knott (doi: 10.5694/mja14.00681) candidly shares his experience of the aftermath of an adverse iatrogenic event that resulted in a patient’s death. He observes that in these situations, it is not uncommon for staff involved to be distressed afterwards and so become “second victims” of the event. He describes the lessons learnt from this particular instance and how a patient-centred approach was important to his own recovery process. Hills and Joyce (doi: 10.5694/mja13.00152) report on their exploratory, cross-sectional study of workplace aggression in Australian clinical practice, conducted as part of the third wave of the Medicine in Australia: Balancing Employment and Life survey. Of the responding clinicians, 27.2% reported experiencing internal aggression (ie, from co-workers) at work, while 67.6% reported experiencing aggression from external sources (eg, from patients) at work in the preceding 12 months. Adjusted and unadjusted analyses found both of these forms of aggression to be consistently negatively associated with job satisfaction, general life satisfaction and self-rated health. It was suggested that, in turn, such negative effects on clinicians’ wellbeing are potentially harmful to the quality and safety of patient care.

Hospitals clearly are a challenging environment for workers’ and patients’ safety, but safety in the community is also important, especially as outdoor recreational activities increase alongside the seasonal temperature. Howden and colleagues (doi: 10.5694/mja14.00567) report their novel study, which attempted to measure the rate of surfboard-related eye injuries in New South Wales over a 1-year period. Ten cases were reported by ophthalmologists, two of which were described as severe. The authors acknowledge that this was likely to have underrepresented the true rate of injury, and they advocate for the development of safety-enhancing modifications to surfboards. Protective eyewear, although unpopular with surfers, was also suggested as worthy of investigation.

While a beach full of goggle-clad surfers may be hard to envisage this summer, it is encouraging to hear of the efforts underway to make our hospitals and communities safer places to be.

Inequalities of access to bariatric surgery in Australia

Bariatric surgery for obesity complicated by severe comorbid conditions should be accessible to all Australians

Severely obese people in Australia can undergo weight loss surgery in the private sector with little difficulty, but publicly insured patients are blocked from equivalent access. A recently published study in the Journal reports that weight loss, improvement in metabolic indices, and clinic attendance after bariatric surgery in public patients compared favourably with that in patients who were privately insured.1 With their findings, the authors’ call for increasing access to bariatric surgery in public patients is an important regional contribution to the national discussion of this vexed question. It is noteworthy that Australia’s world-class contribution to the vast literature on metabolic surgery, which includes randomised controlled trials and authoritative systematic reviews, comes predominantly from work carried out in the private sector.

Bariatric surgery has long been established as the only treatment for the morbidly obese that durably addresses the mechanical effects of obesity, such as sleep apnoea and joint disease, while producing profound metabolic changes including resolution of type 2 diabetes mellitus (T2DM), hypertension and dyslipidaemia. Yet, unlike for other chronic illnesses such as asthma, diabetes and joint disease, Australia still has no framework within which obesity treatment of any kind, including surgery, can be offered to all. While surgery is available for public patients in some Australian states, the services are poorly funded and oversubscribed or, as is the case in New South Wales and Queensland, almost completely absent.

There is solid evidence that the expense of surgery will be offset by reduced costs of managing comorbid conditions, yielding improved quality and length of life, as well as by reduced costs of medication and food.24 For those with T2DM, the savings from eliminating the substantial annual direct and indirect costs of medical treatment can pay for surgery in a year or so.

While the scientific and business cases for bariatric surgery might be strong, in the absence of a coherent funding model, savings accrued in the care of the associated chronic illnesses (largely a federal expense) are not directly available to fund surgical care (a state expense). There is no doubt that persisting attitudes among the medical profession, health administrators and politicians have led to an inadequate will for and understanding of how obesity surgery can be successfully translated into a public hospital setting on a wide enough scale. The prospect of uncontrolled bariatric surgery in the public sector raises the spectre of swelling waiting lists and budgetary overruns from hospital readmissions for revisional surgery and complication management.5,6

While the female preponderance of patients in reported series14,7,8 may fuel the prejudice that bariatric surgery is merely cosmetic, studies examining mortality rates and comorbid conditions9 show that the population of patients ideally targeted in a public bariatric clinic will manifest clear health improvements after surgery. In obese patients with severe comorbid conditions, health is as impaired as in those with malignancy or cardiac ischaemia.10 When faced with an overwhelming demand for a finite resource, a rational approach to cost concerns is to focus on surgery to treat sickness rather than fatness. Body mass index alone is not as good a selection criterion as the presence of serious obesity-associated conditions that are inadequately responsive to standard medical therapies. In this setting, bariatric surgery is best practice.

Treatment-adherent public patients need to be referred for bariatric surgery by a clinician treating their refractory comorbid conditions (eg, tablet-controlled diabetes now requiring insulin). Given the resources being used, the final recommendation for surgery should be made in a multidisciplinary team-like structure. These measures will help assure cost-effective surgery and patient adherence. Equally, performing surgery on patients who are non-adherent with their medical therapies risks their non-adherence to nutritional and supplement advice afterwards.

Innovative public–private collaborations between bariatric surgeons and local health district-based bariatric centres can furnish the case and personnel volume (in excess of 50–100 cases annually per team) needed for a meaningful impact on patient numbers and mandatory to maintain skill levels and clinical coverage for well performed, safe surgery.

The establishment of a definitive dataset for both public and private sectors is now feasible with the development of the Monash University-based Bariatric Surgery Registry.7 Lifelong collection of data vital to the understanding of metabolic disease could be facilitated by the creative use of the national e-health record, with input perhaps from the new generation of wearable computers to track physical activity and metabolic indices. The challenge will be to achieve buy-in by bean counters and bariatric surgeons with the acknowledgement that life-threatening complications of severe obesity merit best-practice treatment.

The medical workforce in 2025: what’s in the numbers?

This is a republished version of an article previously published in MJA Open

Medical workforce supply levels follow a predictable, if lengthy, cycle between phases of shortage and surplus. In Australia we are currently in an upswing stage; there has been significant growth in Australian medical workforce supply in the past decade. Between 1999 and 2009, there was an increase of over 20 000 employed medical practitioners — from around 50 000 to almost 73 000.1 Recent expansion of medical training programs does not largely account for this increase, as graduates of these programs only began entering the workforce in 2006, with the majority entering after 2008.2

While such observed increases may reduce concerns about workforce shortages at the global level, they occur in the context of increasing demand for services at rates beyond population growth. In this article, I review current trends in medical workforce supply levels, identify key policy challenges arising from them and discuss how these might be met to ensure an adequate and sustainable workforce into the future. Emerging workforce policy challenges associated with current trends include reduced participation levels in the workforce and “bottleneck” issues for young doctors trying to enter specialist training programs. Distribution also continues to be a problem despite overall increases in the medical workforce, with imbalances across geographic regions and between specialties.

Reduced workforce effort

The decreasing participation levels of doctors can be seen in a decline in average working hours. In 1999, Australian doctors worked 45.6 hours per week on average. By 2009, this had decreased to 42.2 hours per week.1 This translates to more than 6000 fewer full-time equivalent doctors than would be the case if average working hours in 2009 were the same as those a decade earlier. This decreasing work effort is attributable to an increased proportion of women in the medical workforce, a changing age profile, and changing work–life balance expectations.

Women comprised 36% of the medical workforce in 2009, up from 29% in 1999.1 Women account for only 19% of doctors aged 55 years and over (who as a group represent 25% of the total workforce), compared with almost 50% of doctors aged 35 years and under. The ratio of women to men in the medical workforce is likely to eventually reach 1 : 1, but currently, significant disparities between subgroups remain. While women comprise 39% of the general practice workforce, they comprise only 25% of the specialist workforce. Female doctors, on average, work fewer hours than male doctors (37.5 hours per week compared with 44.9); however, sex differences are less apparent for younger doctors. Female doctors under the age of 35 years work only 2 hours per week less than male doctors. For those aged 25–34 years, the averages are about 44 hours per week (women) and 46 hours per week (men); and for those under the age of 25 years, the corresponding figures are about 46 and 48 hours per week, respectively.1

While the average age of members of the medical workforce did not change between 1998 and 2008, there was nevertheless a changed age distribution during this period. In 2008, there was a higher proportion of doctors aged 55–64 years than in 1998, and a lower proportion aged 35–44 years. This reflects a sizeable group of medical practitioners who entered the Australian medical workforce in the previous “boom” phase in the 1970s. The “demographic hump” created by this group has been steadily moving through the age range and is now approaching traditional retirement age. Doctors who remain in the workforce beyond 65 years of age work far fewer hours than younger doctors. Hence, the coming years will see a considerable number of doctors either retiring altogether or reducing their working hours as they approach retirement. Retirement trends are a major influence on overall workforce supply levels,3 but there is relatively little information currently available on actual retirement patterns. Studies of retirement intentions suggest that one-third of general practitioners plan to retire before turning 65, and that job satisfaction is a key factor in this decision.4 Recent changes to registration arrangements, implemented as part of the move to the national registration scheme, made it more difficult for doctors to “step down” their clinical practice, by removing categories of registration that allowed some continued clinical practice without the requirements of full registration in relation to professional development and indemnity insurance.5 Proposals to remedy this, to ensure that a stepped approach is still a viable option for doctors, were the subject of a campaign driven by the profession.6

Work–life balance issues are increasingly prominent in the minds of doctors of all ages but have been particularly noted among younger doctors.7,8 Hospital non-specialists (a group largely comprising doctors in their early postgraduate years) overall worked fewer hours per week in 2009 than a decade earlier.1 Male hospital non-specialists have reduced their working hours while women have actually marginally increased theirs, so that the difference between the two sexes is now less than before.1 Overall, male doctors have made greater reductions than females to their working hours over the last decade, thus reducing the overall gender gap.1 Choice of specialty is influenced by the perceived work–life balance afforded by a specialty,9,10 and by hours of work and the possibility of time out from the medical workforce.

Bottlenecks in training pathways

The early postgraduate years are a critical time for doctors, when job demands are likely to be high and when many are making decisions about which specialty they wish to practise in for the rest of their working lives.7,10

Since 2000, graduate numbers have doubled; from around 1400 a year to 2733 in 2010. They are projected to increase further, to reach almost 4000 in 2016.11 The number of intern places has been slightly higher (by 5%–10%) than the number of graduates the previous year (Box 1), partly because of New Zealand graduates and other international medical graduates coming into the system (via the Australian Medical Council pathway). The figure also indicates how this gap closed in 2009 and 2010. On the basis of projected numbers of Australian medical graduates, we can anticipate that intern places will need to increase by over 1000 in the next 5 years. Difficulties are already being experienced in attaining sufficient settings and supervisors,12 and these seem likely to continue, or worsen, in the next few years. A broader and more flexible approach to internships is likely to be required to accommodate the growing numbers (eg, incorporating private sector and primary care settings as well as traditional large public hospitals). Achieving this successfully will require cross-sectoral collaboration to ensure comparability of training experiences and appropriate resourcing across settings.13

Typically, medical graduates remain in general postgraduate positions for an additional 1–3 years before entering vocational training programs. Because the timing of entry to these programs varies relative to graduation, it is difficult to estimate the progression of successive cohorts of graduates into this stage.

However, data are available on the number of basic, advanced and total trainees (Box 2). These data indicate relatively little change between 2000 and 2003, followed by significant growth in overall trainee numbers since 2004. Advanced trainee numbers increased 80% between 2001 and 2011, with most of the increase occurring since 2005. Increases have been somewhat uneven across specialties during this period (Box 3). A number of specialties more than doubled their number of trainees, and all clinical patient-care specialties have had some growth. Five new training programs were in operation in 2011 that did not exist a decade earlier. The largest absolute increases in trainee numbers were in general practice (increase of 1429) and adult medicine (increase of 1029). As with internships, a more diverse array of training arrangements is likely to be required for vocational training, with concomitant challenges in maintaining equivalence.

Continuing imbalances and particular shortages

Policy debates are already starting to come full circle, with concerns now being raised about potential oversupply in the medical workforce.14 This mirrors the pattern seen in previous decades, with the 1970s boom (in response to perceived shortages) followed by perceived surpluses through the 1980s and 1990s, which in turn influenced restrictive policies on entry to the medical workforce. To some extent, such swings in perception may be inevitable. To avoid the extremes, it is important to maintain a proactive approach to workforce policy that is informed by good evidence and takes into account both macro-level total supply trends and issues in specific sectors or specialties. For example, workforce supply in non-metropolitan areas remains below levels in major cities.15 Shortages are also apparent in specialties, including orthopaedic surgery, ear, nose and throat surgery, obstetrics, pathology, radiology, oncology, psychiatry and general medicine.16,17 Within the primary care sector, specific services are problematic, such as after-hours services, home visits, and procedural GP services in rural areas. Current programs have invested significant funds to try to redress the shortage of after-hours services and procedural rural GPs, but significant problems remain.18

An adequate and sustainable medical workforce in 2025

Looking forward to 2025, there are a number of clear directions to pursue in order to ensure a medical workforce that is both adequate for the task of meeting the medical care needs of the Australian community, and is sustainable for the long term:

  • Ensuring an adequate workforce in the primary health care sector and rural regions.

  • Developing and maintaining capacity to identify and respond to ongoing and emerging health workforce policy challenges.

  • Accommodating diverse patterns of workforce participation.

The primary health care workforce must remain a priority in order to cope with likely increases in demand associated with an ageing population, increasing prevalence of chronic disease, and a greater emphasis on risk factor management and health promotion. The primary health care workforce of the future is increasingly likely to be a multidisciplinary team, and planning for the future GP workforce needs to take this into account with respect to both the overall numbers and the skills and expertise required.

While the increases already seen in the general practice pipeline are encouraging, additional strategies for increasing participation include promotion of the attractions of general practice as a specialty, including the potential for good work–life balance, flexibility in the training program, and high job satisfaction.19 Exposure during training to positive experiences of general practice may promote uptake of GP careers among medical graduates. Given the importance of relative pay rates for doctors in their choice of specialty,20 increasing GP pay is another potential strategy to support recruitment. However, non-financial incentives (such as controllable hours, flexibility and opportunities for “interesting” work) are also important.20

An adequate rural medical workforce is also likely to be multidisciplinary in nature, and should be supported by best possible use of information and communications technology. Current funding mechanisms do not cover implementing recent technologies (including phone, email and videolink) that have the potential to allow doctors to communicate with patients remotely in a safe and effective way. The introduction of Medicare rebates for video consultations with specialists is a welcome step in aligning funding mechanisms with modern communications technologies. However, numerous other options that allow doctors to communicate with patients or with other health professionals at a distance (such as email, remote monitoring by phone or internet, or remote review of images) are yet to be incorporated into standard funding and service models.

The establishment of Health Workforce Australia (HWA) is an important milestone in the development of national capacity for workforce planning and policy. HWA has a key role to play in identifying and responding to specific shortages while also monitoring the big picture of workforce supply and demand, to minimise as far as possible the boom–bust cycle. Monitoring of shortages in specific specialties was undertaken in a detailed fashion by the Australian Medical Workforce Advisory Committee during its tenure from 1996 to 2006, but more recently attention has shifted to big picture issues and reform. Both levels must be attended to for effective workforce planning and policy.

HWA needs to build its capacity to collect and analyse data and to communicate to policy decisionmakers the important trends and patterns indicated. Workforce policy needs to be informed not just by the “profile” characteristics kept in HWA datasets, but by information explaining individual decision making — why doctors are making the choices they are, and what potential there is to influence those choices with policy levers.

The changed expectations and preferences of doctors with regard to working hours and participation will need to be matched by a range of strategies to accommodate such preferences, to prevent even greater losses of work effort over the career span. This may include more flexible leave and part-time arrangements in employment and training, as well as facilitation of re-entry to the medical workforce. It has been suggested that doctors approaching retirement could be engaged in medical education,21 a strategy which has the potential to retain older doctors and increase their job satisfaction, while also meeting the educational needs of younger doctors. Significant gaps remain in an understanding of factors influencing doctors’ choices about workforce participation during the late career, pre-retirement stage. Such information is of crucial importance in maintaining the attachment of these doctors to the workforce.

Innovative care models are likely to be required to meet demand for after-hours care. Many new approaches are already in place, such as call centres and help lines, GP clinics co-located with emergency departments, nurse triage services and so on. Such strategies should be expanded and further developed. Many of these alternatives incorporate an element of skill-mix changes, and further innovation in scope of practice for non-medical health professionals (including new roles such as physician assistants and nurse practitioners) has the potential to significantly alter future medical workforce requirements.22

Conclusion

In contrast to the traditional focus of medical workforce policy and planning on the supply pipeline, the future will be more about influencing the decision making of doctors currently in the workforce in relation to working hours, location of practice, specialty field and workforce participation. This is particularly so for doctors in the early stages of their career, who are making decisions about specialty disciplines and working styles, and for doctors at the other end of their career, who are approaching retirement. Key determinants operate at the systemic level, such as availability of training places and financial factors, and at the individual level, such as professional support, working hours, job satisfaction and the flexibility or predictability of work. Understanding these determinants is of critical importance for effective medical workforce policy in the future.

1 Numbers of Australian medical graduates (domestic and total), and number of intern places*

* Actual numbers shown up to 2010, and projected numbers of graduates for 2011–2016.11 Numbers of intern places are shown lagged by 1 year to display the relationship to the number of graduates in the previous year (eg, data shown for internships for 2003 is number of internships in 2004, which are largely taken up by 2003 graduates).

2 Vocational trainees: basic, advanced and total trainee numbers, 2000–2011*11

* Some colleges report number of trainees while others report number of accredited positions.

3 Percentage change in number of advanced trainees, by specialist training program, 2001–201111

Change in no. of advanced trainees

Specialty*


High growth (> 100%)

Adult medicine

Emergency medicine

Intensive care

Paediatrics

Psychiatry

Rehabilitation medicine

Radiation oncology

Growing (25%–95%)

Anaesthesia

Anaesthesia — pain medicine

Dermatology

General practice

Obstetrics and gynaecology

Occupational and environmental medicine

Ophthalmology

Pathology

Pathology and RACP jointly

Radiodiagnosis

Surgery

Steady (± 10%)

Public health medicine

Medical administration


RACP = Royal Australian College of Physicians. * Four programs operating in 2011 commenced since 2009 and are not included: addiction medicine, palliative medicine, sexual health medicine and sports and exercise medicine. Due to changes in reporting practices, figures for these specialties are calculated from later time points: psychiatry and ophthalmology from 2005; anaesthesia (pain medicine) from 2006; dermatology from 2007; and obstetrics and gynaecology from 2008. Program commenced in 2006.

International medical migration: what is the future for Australia?

This is a republished version of an article previously published in MJA Open

Despite goals for self-sufficiency, migration seems certain to remain an imperative for Australia for the foreseeable future

Australia has developed extraordinary reliance
on international medical graduates (IMGs) compared with other OECD (Organization for Economic Co-operation and Development) countries. Based on analysis of an unprecedented range of secondary data, I aim to define the recent scale and sources of medical migration, IMGs’ immigration categories, their distribution, their performance in the Australian Medical Council examinations, and the impact of the Competent Authority Pathway.

From the 2005–06 financial year to 2010–11, 17 910 IMGs were sponsored to Australia on a temporary basis, with a further 2790 selected as permanent skilled migrants.1,2 Thousands of additional IMGs arrived unfiltered in advance for human capital attributes, admitted as spouses and through Australia’s family or humanitarian categories. Recent IMGs have trained in highly diverse countries, associated with very variable English language testing results and medical registration and employment outcomes.

Despite such challenges, I argue that Australia’s reliance on IMGs is likely to be maintained in the future, owing to a combination of factors. First, medical migration remains Australia’s key strategy for addressing medical workforce maldistribution, with competition to recruit and retain medical migrants recently intensifying rather than diminishing. Second, the Competent Authority Pathway for registration has improved IMGs’ outcomes, enhancing their immediate value as a source of supply. Third, Australia has become increasingly reliant on internationally trained specialists to serve in select undersupplied fields. Fourth, there is growing Australian demand for international medical students, who achieve exceptional early outcomes relative to IMGs. Despite greatly enhanced investment in domestic student training, Australia’s dependence on international migration thus appears likely to persist rather than reduce in the foreseeable future.

Australia’s level of dependence on
medical migrants

By 2006, 45% of medically qualified residents were overseas-born, including an estimated 25% who were overseas-qualified.3 In 2001–2006, 7596 doctors migrated to Australia across all immigration categories — double the number admitted from 1996 to 2000. India, the United Kingdom/Ireland, Sri Lanka/Bangladesh, China, other southern and central Asian countries, North Africa/the Middle East, South Africa, sub-Saharan Africa (excluding South Africa), and the Philippines were the primary source countries at this time (Box 1).4

Medical workforce diversification has proven challenging, however. Just 53% of IMGs who arrived in Australia during 2001–2006 secured medical employment by 2006 (across all immigration categories). Doctors from English-speaking countries made the transition seamlessly, while Asian-Commonwealth doctors from countries such as Singapore and Malaysia, India, Sri Lanka and Bangladesh fared reasonably well. Outcomes were poor for many other birthplace groups (Box 1). Just 6% from China had found medical employment within 5 years, 23% from Vietnam and 31% from Eastern Europe. Many had arrived through the family and humanitarian categories — untested in advance for employment attributes or registerability.4 Thousands were also admitted as spouses. Large numbers of recently arrived IMGs were defined as “not in the labour force” — a proxy for learning English and/or trying to pass preregistration exams. English testing for example was a powerful barrier. By 2010, a pass rate of only 43% was the Occupational English Test norm for medical applicants, rising to 52% in 2011.1

Despite highly diverse source countries, workforce integration is best for IMGs selected through Australia’s 457 visa temporary sponsored pathway (99% employed at 6 months), followed by those entering under the permanent General Skilled Migration Program. These flows now dominate (Box 2). This pathway is highly attractive to governments and employers given the potential to prescribe IMGs’ location as a condition of visa entry, allowing them to work for up to 4 years at undersupplied sites.

By 2009, 70% of labour migrants were sponsored, reflecting the recent dramatic privatisation of Australia’s skilled migration program. From 2005–06 to 2009–10, 34 870 health professionals were selected as temporary 457 visa migrants. Nurses (46%) and doctors (44%) dominated. A further 2420 visas were awarded to temporary IMGs in 2010–11: 1190 for general medical practitioners and 1230 for resident (house) medical officers (mostly new appointments). In 2010–11, most such IMGs were recruited to Victoria (600), New South Wales (540), Queensland (500) and Western Australia (280).2 From 2004–05 to 2009–10 an additional 15 940 General Skilled Migration category migrants holding health qualifications were admitted permanently, primarily qualified in nursing (52%), medicine (15%) and pharmacy (13%). In 2010–11, 460 more IMGs were approved.1,2

Additional doctors arrive from New Zealand — enjoying free entry rights under the Trans-Tasman Mutual Recognition Arrangement, in a context where 12% of the New Zealand population is currently resident in Australia. By 2006, 1163 New Zealand physicians were based in Australia, including 240 admitted from 2001 to 2006.1

Performance in the Australian Medical Council examinations

New Zealand doctors face no employment barriers in Australia. Analysis of 28 years of Australian Medical Council (AMC) data, however, reveals that other IMGs experience highly variable registration outcomes. The most detailed study to date, commissioned by the Department of Health and Ageing, showed that just a third of recently arrived IMGs had attempted to pass the AMC preaccreditation exams in the years preceding 2007. Of those IMGs attempting it, 78% were medically employed within 5 years, despite just 41% having by then secured unconditional registration.5

According to the AMC Submission to the House of Representatives Standing Committee on Health and Ageing Inquiry into Registration Processes and Support for Overseas Trained Doctors (2011) and additional data provided to me, from 2004–10, 57% of IMGs aged 21–30 years passed the multiple choice question examination on their first attempt, compared with 46% aged 41–50 years and 31% aged over 50. Similar trends were evident in the clinical examination.6 Box 3 reports outcomes by the top 10 countries of training.

In 2008, given mounting concern, the Australian Government initiated “a national assessment process for overseas qualified doctors to ensure appropriate standards in qualifications and training as well as increase the efficiency of the assessment process”.7 Multiple pathways to practice have since developed, including the fast-track “Competent Authority” option for doctors registered in New Zealand, the UK, Ireland, the United States and Canada. Eligible source countries may opt out — Singapore and South Africa have done so to minimise workforce loss.6 For IMGs requiring greater periods of adjustment, alternative pathways have been designed to provide enhanced supervision, address differential levels of training need, and increase readiness for specific locations of practice.

Factors affecting Australia’s reliance on IMGs

To redress medical workforce undersupply, Health Workforce Australia has been charged by the Australian Health Ministers’ Conference with developing a national training plan. The goal is to reach self-sufficiency by 2025.

In the foreseeable future, however, medical migration seems certain to remain an imperative for Australia, given Australia’s ageing patient and practitioner base, reduced hours worked by younger cohorts, the growing feminisation of medicine, limited access to internship places, and distribution challenges. The Department of Immigration and Citizenship has recently set “occupation ceilings” for skilled migration in 2012–13. In medicine, the ceiling is 4860 people, compared with 15 660 in nursing, 1380 in pharmacy and 720 in dentistry (numbers are reported at http://www.immi.gov.au/skills/skillselect).

Migration remains Australia’s key strategy for redressing medical workforce maldistribution, with states intensifying competition to recruit and retain IMGs

Between June 2000 and December 2002, 5304 temporary IMGs were sponsored to “areas of need”. This level of dependence has been maintained, with 3860 IMGs selected by states or territories in 2007–08 compared with 3310 a year later. In 2008–09, based on state and territory medical board or medical council data, 17 141 doctors were employed under various forms of conditional registration. Further, 2695 IMGs were employed through “area of need” registrations (primarily in Queensland [50%]), with Australia remaining highly reliant on medical migrants for primary care in remote or very remote sites.3 Definitions of eligible areas have also been extended rather than reduced. In 2007, larger regional centres characterised by significant workforce shortages were included.8 Following 5 years of service in an area of need, IMGs can apply for permanent resident status.2

By 2010, 46% of doctors in rural and remote practice in Queensland were overseas-trained. Thirty-six per cent of the 1209 GPs working in rural and remote Victoria had obtained their basic medical qualification outside Australia, primarily in south Asia (11%), the UK or Ireland (7%), Africa (5%), eastern Europe (4%) and the Middle East (3%). IMGs constituted 53% of rural and remote GPs in WA, and were derived from 33 countries of training — double the level of reliance in 2002.912 The majority were 457 visa (or equivalent) temporary sponsored arrivals, typically working under various forms of conditional registration. This practice has become widespread in the past decade, despite growing concerns for the risk of developing “two-tier” medical care.6 New governance systems have been introduced through the 2010 establishment of the Australian Health Practitioner Regulation Agency;13,14 however, these have coincided with concern about red tape related to changed recruitment and registration procedures.15

Australia’s Competent Authority pathway has recently transformed IMG recruitment while enhancing their value as a source of supply

From July 2007 to late 2010, 4955 Competent Authority applications were received by the AMC, and 3327 Certificates of Advanced Standing were issued. This process had been successfully completed by 1990 applicants from 56 countries of training by December 2010, a year when 1281 assessments were handled.6 In an unanticipated consequence, the Competent Authority model also enhanced Australia’s global competitiveness. From 2007–10, the Competent Authority pathway attracted relatively young applicants; 54% of those issued Advanced Standing Certificates were aged 21–30 years, compared with 38% aged 31–40 years. UK-trained applicants were the major beneficiaries (1019), followed by IMGs qualified in India (422) and Ireland (176). Massive growth in arrivals who qualified in the UK or Ireland has occurred, surging to around 3000 in 2007–10, compared with up to a hundred per year previously.16 These IMGs enjoy strong employment outcomes, despite debate over
a registration scheme that allows thousands of IMGs to practise on a supervised basis.

Australia has become increasingly reliant on internationally trained medical specialists to serve
in undersupplied fields

In recent decades, Australia’s dependence on IMGs has also become marked in select specialties. From 2004 to 2010 the AMC handled 6604 IMG specialist applications, primarily in the fields of anaesthesia (13%), psychiatry (11%), obstetrics and gynaecology (8%), diagnostic radiology (8%) and general surgery (6%).1 Most were from men (69%), with the top five countries of training being the UK, India, South Africa, the USA and Germany.

In terms of psychiatry, for example, disproportionate numbers of IMGs now work on temporary 457 visas in underserved sites.17,18 They compensate for an exodus of domestic psychiatrists from public sector and regional practice, who work in large cities in affluent suburbs, near private hospitals where they admit their patients.19 Rural psychiatrists, by contrast, typically lack access to urban amenities, quality schools and employment for their spouse. Many are on call 24 hours per day, 7 days a week, providing mental health services in regions characterised by gross undersupply.19 Comparable IMG dependence prevails in many specialties.

There is now growing Australian demand to recruit and retain international medical students

Former international students have emerged as a key medical resource for Australia. By definition they are characterised by youth, full registration, and significant acculturation. They have funded themselves to meet Australian professional standards, and face none of the IMGs’ barriers.

By December 2009, close to 3000 international students were enrolled in medical courses (and this has since accelerated). In 1999, following removal of a 3-year eligibility bar, they became immediately able to migrate.20 As demonstrated by Australia’s Graduate Destination Survey, since 2006, retention of international medical students has tripled, with large numbers wishing to migrate. They achieve nearly identical immediate employment and salary outcomes to domestic graduates. By 2010, 98.9% were employed full-time, compared with 99.7% of domestic graduates. Analysis of the Medical Schools Outcomes Database and Longitudinal Tracking Project shows 78% of final-year international students initially stay — virtually all graduates, once sponsored students are excluded.21,22 While the ethics of international student migration remain a matter of debate, parents rather than source countries have resourced their education. From an ethical perspective, their recruitment is less problematic than the normal recruitment method of OECD countries — selection of mature-age medical professionals fully trained by their countries of origin.23,24

Conclusion

Between 2004 and 2009, the number of Australian domestic medical completions rose from 1287 to 1915. Provisional registrations rose from 1699 to 2955.25 Incentive schemes were also developed (most notably the Bonded Medical Places Scheme, to which 25% of all first-year Commonwealth supported medical school places are allocated) to encourage medical graduates to serve in areas with an undersupply of doctors. Despite such measures, dependence on IMGs seems certain to remain strong, as confirmed by the recent House of Representatives inquiry into overseas-trained doctors.15 Australia is not alone in this reliance, which is intensifying across OECD nations.2629 The challenge will be positioning to recruit and retain “the best” medical migrants, in the context of the highly variable registration and employment outcomes that many initially achieve. To facilitate this, collective action by all relevant jurisdictions will be essential.

1 Labour market outcomes for degree-qualified Australian and New Zealand-born medical graduates, compared with migrant medical graduates arriving
2001–2006 (2006 census)*

Employed


Other


Birth country

Number

Own
profession

Other
profession

Sub-total

Unemployed

NLF


Australia/New Zealand

39 381

58%

29%

88%

1%

12%

United Kingdom/Ireland

1 004

71%

14%

85%

15%

Northern Europe

39

51%

18%

69%

31%

Western Europe

328

62%

20%

81%

2%

17%

South-eastern Europe

132

49%

24%

73%

2%

25%

Eastern Europe

160

31%

26%

56%

6%

38%

Vietnam

64

23%

25%

48%

5%

47%

Indonesia

73

8%

16%

25%

16%

59%

Malaysia

227

62%

5%

67%

3%

30%

Philippines

256

50%

27%

77%

5%

19%

Singapore

65

63%

14%

77%

23%

China (not SAR or Taiwan)

590

6%

47%

53%

11%

36%

Hong Kong/Macau

38

40%

40%

79%

21%

Japan/South Korea

102

14%

28%

42%

10%

48%

Other southern and central Asia

364

43%

10%

53%

7%

40%

India

1 378

61%

12%

73%

7%

20%

Sri Lanka/Bangladesh

691

56%

16%

71%

7%

21%

Canada/United States

201

48%

17%

65%

2%

33%

Central/South America

117

40%

30%

70%

13%

17%

South Africa

496

75%

18%

93%

1%

5%

Other sub-Saharan Africa

342

71%

6%

77%

7%

16%

North Africa/Middle East

564

47%

13%

60%

10%

31%

Other

365

56%

20%

75%

3%

22%

Total migrants

7 596

53%

18%

71%

6%

23%

NLF = not in the labour force. SAR = Special Administrative Region. – = insufficient cases for reliable reporting and issues of confidentiality. Many of the cells are based on very small numbers, therefore
the results should be regarded as indicative only.

* Source: UNESCO global comparison study, Table 23.4 Excludes those for whom birthplace or year
of arrival is unknown. Due to missing data, imputation and aggregation, numbers may not add up
to 100%.

2 Top 10 recent source countries for permanent and temporary migrant health professionals, 2005–06 
to 2009–10*

Country

Permanent migrant health professionals

Country

Temporary migrant health professionals


United Kingdom

4120

United Kingdom

9350

India

1510

India

6420

Malaysia

1300

Philippines

1850

China

970

South Africa

1770

Philippines

510

Malaysia

1570

South Africa

500

Ireland

1560

Republic of Korea

480

China

1380

Egypt

420

Zimbabwe

1180

Singapore

390

Canada

950

Ireland

350

United States

830


* Source: Scoping paper for Health Workforce Australia, Table 6, p. 51,
based on Department of Immigration and Citizenship data, reported by financial year.1 General skilled migration primary applicants; total all sources, 13 880. 457 long-stay business visa primary applicants; total all sources, 34 870.

3 Australian Medical Council clinical examination outcomes by top 10 countries of training, 2004–2010*

Top 10 countries
of training

No. of
candidates

Pass

Fail

Retest


India

1823

52%

29%

19%

Bangladesh

799

42%

38%

20%

Pakistan

665

48%

31%

21%

Sri Lanka

660

58%

22%

20%

China

594

58%

23%

19%

Iran

481

56%

27%

17%

Philippines

437

34%

46%

20%

Burma

374

47%

31%

22%

Iraq

333

52%

29%

19%

Egypt

277

52%

29%

19%

Other countries

2646

58%

26%

16%

Total candidates

9089

53%

29%

19%


* Source: Scoping paper for Health Workforce Australia, Table 29, p. 97, based on Australian Medical Council data, reported by calendar year.1

Sustainable workforce and sustainable health systems for rural and remote Australia

This is a republished version of an article previously published in MJA Open

Lack of access to quality health care providers is one of the primary root causes of health inequity and is disproportionately experienced by people living in remote and rural communities.1

Recruiting and retaining an appropriately skilled health workforce in sufficient numbers is a central plank of rural health policies and programs globally. Currently in Australia, there is tension between national health workforce policy initiatives designed to address the rural workforce problem and several broader countervailing demographic, socioeconomic and political forces. National policies, on the one hand, offer various incentives to take up practice in rural and remote areas; have increased numbers of training places for doctors, nurses and allied health professionals; have provided rural student scholarships; have restrictive elements that account for the high proportion of international medical graduates in rural Australia; and have fostered the development of regional academic infrastructure designed to provide students with rural and remote-based training.2 On the other hand, these initiatives are occurring against continued rural population decline, industry contraction (mining excepted), small town settlement demise, service rationalisation, and the ageing of both the rural and remote population and the health workforce.3,4

The evidence for whether current workforce positive initiatives are overcoming the health workforce maldistribution in Australia is inconclusive.5 While
trends show increasing numbers of doctors across both metropolitan and rural areas6 and increasing numbers
of nurses in all but very remote areas,7 the changing aspirations and work patterns of recent graduates explain why the number of effective full-time workers does not show a commensurate increase.8 In addition, changes
in demography will result in shrinkage of the entire workforce and markedly lower rates of overall workforce entry.4 It is too early to tell whether the significant increase in medical student numbers will result in increased numbers of doctors in rural and remote regions.

The current workforce shortage in remote and rural areas is reflected in and exacerbated by the significant disparity in health resource distribution between metropolitan and rural Australia. Available per capita expenditure data for both primary and secondary care utilisation amount to an estimated shortfall in excess of $2 billion.5,9 Moreover, many small rural communities have experienced ongoing problems with maintaining health staff and hospital services, such as local birthing services.10 This demise of local procedural services reflects not just population loss and ageing, but also the continued rationalisation of these services in regional centres as health authorities continue to be guided by fiscal policies rather than by those aimed at maximising the health and wellbeing of the population.3

At the same time, health status is, on the whole,
worse in non-metropolitan Australia. For example, life expectancy decreases with increasing remoteness; it is 1–2 years and up to 7 years lower in regional and remote areas, respectively, compared with major cities. While much of this gap is due to the higher proportion of Aboriginal and Torres Strait Islander people in rural areas, the probability of non-Indigenous Australian men and women living to 65 years is 2%–3% and 1% lower in regional and remote areas, respectively, compared with major cities.11 Thus rural and remote populations have the highest health needs while experiencing the poorest access to health and community services.

Where should we be in 2025?

To ensure equity in health outcomes, we need to provide accessible, appropriate, affordable health services, regardless of geography. A focus on health workforce issues alone will not achieve optimal health outcomes for all Australians. We envision a health system that privileges primary health care and disease prevention; that ensures coordinated care; and that employs a variety of service delivery models appropriate to context, each addressing
an evidence-based set of essential service requirements.

In pursuing a national health reform agenda, the current Australian government has made explicit an appealing picture of what health services should be available in the future. There will be a greater emphasis on primary health care (PHC) and disease prevention, with a focus on chronic disease prevention and coordinated care for those with (expensive) chronic diseases to ensure effective secondary prevention. The new National Primary Health Care Strategy, the increased focus on prevention with the establishment of a National Preventive Health Agency, and many of the current health care reform initiatives reflect the planned, patient-centred, integrated, comprehensive PHC services, well coordinated with secondary and tertiary services, to which we should aspire.

Sustainable PHC services are likely to bring about the biggest improvement in health outcomes in rural and remote areas because they address outstanding issues
in the broader environment that affect morbidity and mortality patterns in these areas,12,13 they will improve patient access through the complex maze of the current health system and improved early intervention will minimise the need for expensive secondary care.14,15

Arguably, different models of service delivery and workforce configuration will be required to meet the different rural and remote contexts. These will range from traditional fixed services, to “hub-and-spoke” models, visiting services, and telehealth and telemedicine.16 Regardless of the model, however, all services will need to be underpinned by a number of essential requirements — including adequate funding through an appropriate financing mechanism; sufficient number and mix of health professionals; adequate infrastructure, both physical and information and communication technology; strong internal and external linkages; high-quality management, governance and leadership; and rigorous performance evaluation.17

What are the challenges in getting there?

Many effective, sustainable rural and remote PHC models exist, together with evidence they can improve health outcomes and sustain an appropriate health workforce.18 There is also evidence of how health policies and programs affect rural populations.19 If we know what works and what does not, why are there continued barriers to achieving accessible, sustainable, integrated, comprehensive and adequately staffed health services in the bush?

One critical challenge is the predominant “deficit” view of working in the bush.20,21 For too long, the media have focused on the negative views of rural and remote life. This view is often perpetuated by professional bodies and researchers advocating for “a better deal for the bush”, and has ultimately made the problem of workforce recruitment more difficult.

Although health workforce reform remains integral to the provision of adequate and appropriate care in rural and remote areas, workforce problems need to be addressed in the context of other essential service requirements. The challenge of developing comprehensive teams of health workers and generalist programs of training across the nation22 is embedded in the need to develop a rational macro policy environment; to provide adequate funding; to ensure strong management, governance and leadership; and to support strong community participation in PHC and Local Hospital Network governance. Our research
has highlighted the importance of genuine community participation, which takes different forms in different contexts, in the provision of effective sustainable primary health services for rural and remote communities.18

Getting the policy settings right is necessary in order to, inter alia, attain greater clarity in federal–state accountabilities in the current reforms. Unfortunately, strong leadership for rural health care from politicians
has often been lacking. Appropriate policy is also linked
to ensuring adequate funding based on need and, importantly, the capacity to generalise successful models. We have previously described cases of successful Aboriginal community-controlled multipurpose services, hub-and-spoke visiting allied health services and discrete general practitioner-led primary care services.18 With some exceptions, such as multipurpose services, Australian governments have displayed difficulty in generalising effective models and pilot programs into coordinated, national programs. Part of the reason for this has been the lack of consistent, reliable data from systematic, rigorous measurement of outputs and health outcomes as they relate to inputs. Rigorous health service evaluation can both contribute to health service quality improvement
and inform evidence-based policy and practice.16,23,24 Governments also need to move away from the dominant silo mentality to a genuinely whole-of-government approach in order to meet the health needs of rural and remote communities and address the underlying social and economic determinants of health.

How will we overcome these workforce impediments?

Even with strategic policies to guide rural and remote programs, their implementation remains notoriously slow in Australia.25 Indeed, incrementalism remains the norm. More radical change is required on at least four fronts.

Changing the prevailing ethos about rural and
remote health

We need to provide a “realistic job preview” for the potential rural and remote health workforce that better describes both the challenges and positive attributes of living and working in the bush. There is ample lived experience and documented evidence about the joy of rural living20 and about increased job satisfaction and work engagement.26,27 We need to build on these strengths and not focus solely on the challenges.

Workforce education and training

There is a need to address persistent training gaps for allied health and nursing professionals, both at an undergraduate and postgraduate level, appropriate to context. For international medical graduates, improved and consistent orientation and preparation is needed.28 There is also scope to explore the benefits of alternative workforce roles, including generalist training and providers such as physician assistants and nurse practitioners.29 Initiatives such as full-year rural generalist internships are needed to expand and strengthen rural medical generalist training. These initiatives can all build on existing rural and remote academic infrastructure. Many of the pieces of the education and training puzzle are in place — Rural Clinical Schools, university departments of rural health, the RAMUS (Rural Australia Medical Undergraduate Scholarship) scheme, and so on. There is evidence of the effectiveness of increasing rural exposure and training in rural environments for medical students30 and other disciplines.31,32 These programs need to be better integrated and expanded to improve geographical coverage and to enhance involvement of non-medical disciplines with a view to creating team-ready graduates.

Comprehensive service models

Addressing workforce in isolation from other essential service requirements is not effective. A systemic approach that ensures adequate funding, infrastructure, effective management and governance, community participation, and professional development opportunities has been shown to minimise recruitment problems and result in workforce stabilisation. Rural and remote health services have always been incubators of health service innovation (Royal Flying Doctor Service, telehealth, multipurpose services, “cashing-out” to compensate for lack of Medicare income in areas with few doctors, de facto “academic health science systems” with close collaboration between researchers and health services, etc). At the same time, information and communication technology infrastructure in many locations is not adequate for current education and service delivery needs. It is hoped that the rollout of the National Broadband Network, and associated telehealth initiatives introduced in July 2011, will enhance service access. At the same time, this must not be viewed as a panacea to workforce recruitment problems, but rather as an adjunct to support effective teams on the ground.

Accountability

Evaluation of health services will be enhanced through agreed indicators and benchmarks for health inputs and outputs. The availability of reliable national health and workforce data and improved monitoring and evaluation will provide essential information to policymakers, practitioners and health consumers about the impact of current and future investments. While there are existing mechanisms of accountability to some communities, for example the election of community boards of Aboriginal community-controlled health services, with this additional information all communities will know what type and level of services they can expect in a given location. Improved monitoring and evaluation will provide evidence about program effectiveness and value. An improved measure of access will also assist with equitable resource allocation and help to determine the effectiveness of health service development.

Conclusion

While recognising the unique characteristics that distinguish urban, rural and remote Australia, we need to be more cautious about the “city versus country” division, which appears to have been exacerbated by recent national political tensions over balance of power. We also recognise the realities of political power and the struggle over limited resources. Nonetheless, metropolitan and rural Australia remain closely interdependent. Ideally, a bipartisan acceptance that the national health of the population
and economy is a function of thriving cities, country towns and remote settlements may lead to a more sustainable economic base for non-metropolitan communities.

The vision of an effective and accessible rural and remote health system is attainable and a number of policy settings are in place. Rural and remote health workforce difficulties are not insurmountable. They can be overcome by changing the way we view and talk about rural and remote areas. These are places of challenge and opportunity. The challenges of fewer health resources, greater sickness and obtaining access to a range of services are undeniable. However, the rewards of rural and remote practice can be great and the opportunity to effect change in small rural communities can be enormous. The potential for fostering innovative service approaches, the possibility of solving problems at both individual and community levels and the amenity of a rural lifestyle are all positive aspects that attract and retain health workers. Evidence indicates that professional satisfaction with rural and remote practice is at least as high as in metropolitan areas.27 We need to dispel the notion that take-up of rural and remote practice is a “sentence for life”! It has been the most rewarding and formative stage of a lifelong career in health for many doctors, nurses and allied health professionals.

Towards best practice in national health workforce planning

This is a republished version of an article previously published in MJA Open

National health workforce planning is not a new concept. In 1995, the Australian Medical Workforce Advisory Committee (AMWAC) was established under the Australian Health Ministers’ Advisory Council (AHMAC) to “assist with the development of a more strategic focus on medical workforce planning in Australia”.1 In 2000, the Australian Health Workforce Advisory Committee (AHWAC) was established by AHMAC to oversee national-level, government-initiated health workforce planning in Australia, covering the nursing, midwifery and allied health workforces. Following a review of AHMAC workforce committees, AMWAC and AHWAC ceased operating in June 2006; however, at the same time, the Council of Australian Governments (COAG) agreed to a significant national health workforce reform package which included the establishment of the National Health Workforce Taskforce (NHWT). The NHWT was a time-limited entity created to develop strategies to meet the National Health Workforce Strategic Framework outcomes.

Each of these organisations carried out national health workforce planning. The importance of national workforce planning is recognised, given the challenges Australia is facing to its health workforce now and into the future. Such challenges are well documented2,3 and include an ageing population; expected increased demand for health services and increasing expectations for service delivery; changing burden of disease; and broader labour market issues. The national health reform agenda also reinforces the importance of national workforce planning. The majority of health expenditure relates to the health workforce,4,5 so any system reform subsequently has an impact on workforce. For example, many recent reforms have focused on the delivery of primary health care — the introduction of Medicare Locals, GP Superclinics and support for new roles such as nurse practitioners through enabling access to the Medicare Benefits Schedule — all of which will affect the primary care health workforce. The importance of national workforce planning was also reinforced by the National Health and Hospitals Reform Commission, which noted in 2009,

. . . while the Australian health system has many strengths, it is a system under growing pressure, particularly as the health needs of our population change. We face significant challenges, including large increases in demand for and expenditure on health care, unacceptable inequities in health outcomes and access to services, growing concerns about safety and quality, workforce shortages, and inefficiency.6

Health Workforce Australia and national health workforce planning

In 2008, COAG agreed to the National Partnership Agreement on Hospital and Health Workforce Reform, which acknowledged that a national, coordinated approach to health workforce reform with a particular focus on linking efforts of health and higher education sectors was necessary. Subsequently, Health Workforce Australia (HWA) was established as the national agency to progress health workforce reform in Australia and address the challenges of providing a skilled, innovative and flexible health workforce. HWA is a Commonwealth statutory authority, the HWA Board is its governing body, and HWA reports to the Standing Council on Health (SCoH, previously the Australian Health Ministers’ Conference).

The Australian Health Ministers’ Conference commissioned HWA to undertake a workforce planning exercise for doctors, nurses and midwives over a planning horizon to 2025. This project was to present (and measure) possible future health workforce outcomes and training implications under a range of workforce planning scenarios. It was initially known as the National Training Plan; however, in recognition of the fact the planning scenarios identify a range of future health workforce outcomes arising from various potential policy options, of which training is only one, the report has been renamed Health Workforce 2025 — Doctors, Nurses and Midwives (HW 2025). HW 2025 was conducted in two phases. Phase 1 developed projections for the size and type of the health workforce (doctors, nurses and midwives) needed to meet future service requirements from 2012 to 2025 under a range of alternative “futures”, including:

  • moving to self-sufficiency (demonstrated by modelling reducing overseas migration);

  • productivity gains over the projection period;

  • capped working hours for doctors; and

  • changing nursing retention rates.

Phase 2 modelled the training pipeline necessary to meet the size and type of the health workforce identified in phase 1. That is, it provides the estimated numbers of professional entry students, graduates and trainees (for doctors) required between 2012 and 2025 to achieve a workforce in balance at the end of the planning period. Results of HW 2025 were presented to the Australian Health Ministers through the SCoH in April 2012.

In developing HW 2025, HWA followed a number of key principles to ensure the projections are robust, realistic, sophisticated and able to be applied nationally.

Key principles

Authoritative national planning approach

While all states and territories have conducted health workforce planning, such planning is for their own specific purposes and is conducted using different datasets, assumptions and methodologies. This means the projections developed are generally not comparable or able to be aggregated to present a national picture. HW 2025 has been developed to be able to provide this authoritative national approach with its use of a consistent methodology and national data.

Methodological robustness and coherence

Development of the modelling technique employed in HW 2025 involved consideration of a broad range of literature relating to health workforce planning and modelling. The principal method chosen was simulation modelling using a stock and flow approach, together with scenario analysis. The supply modelling tool uses a dynamic version of the stock and flow approach, while demand modelling is based on applying service utilisation rates for 5-year age and sex cohorts together with population projections to derive the rate of change in demand over the projection period. For midwifery, birth rates together with utilisation data were used to calculate demand.7

The same methodology and modelling tools were applied across the doctor, nursing and midwifery workforces to generate the projections. This consistency and coherence in application therefore allows for meaningful comparisons and policy considerations at a national level.

Use of national data

The use of consistent methodology and modelling tools was supported by the use of national datasets. All input data were sourced from nationally comparable datasets. This means the characteristics of the existing workforces and derived items such as exit rates were all developed on the same basis across Australia. While other data sources may exist that provide greater detail or accuracy, such sources only cover individual sectors, states or territories and they could not easily be used for national modelling. The use of national data therefore reinforces the coherence and consistency of applying the same methodology across workforces to allow for meaningful national comparisons. A list of the key datasets used in HW 2025 is provided in the Box.

Explicit assumptions

Projections provide likely outcomes depending on the assumptions on which they are based. If any of the assumptions are not applicable, or cease to reflect real-world situations, the projections will not provide an accurate indication of future outcomes. To ensure the assumptions underpinning HW 2025 modelling were realistic and defensible, they were exposed for critical review through an extensive consultative process. The underpinning assumptions are also available with the publication of the projections to ensure the results can be interpreted accurately. In recognition of changing circumstances that may have an impact on the assumptions made in the initial version of HW 2025, the underpinning assumptions will be reviewed regularly to ensure their ongoing relevance.

Consultation and review processes

HW 2025 projections are generated from the methodology, data and assumptions used. To ensure the relevance of the projections to the doctor, nursing and midwifery workforces, these three aspects were consulted on extensively in the development of HW 2025. In particular:

  • A Technical Reference Group composed of representatives from academia, government and the health sector was created to provide advice and expertise on issues including the appropriateness of the modelling assumptions and best-practice approaches to quantifying education and training capacity and modelling workload measures.

  • The methodology paper was available for public comment.7

  • Structured workshops were conducted with workforce participants and organisations to expose the overall method and the assumptions underlying the baseline projections to critical review.

  • Clinical leads (health professionals representing each of the fields of medicine, nursing and midwifery) provided clinical expertise and context to modelling and pipeline analysis and the development of alternative scenarios.

  • Clinical Advisory Groups were established to develop and test the assumptions underlying phase 2 pipeline projections.

  • A Geographical Distribution Expert Reference Group was created to provide expert advice on regional distribution issues.

The engagement and input of these groups was vital in ensuring HW 2025 generated realistic and useful projections.

Scenario and sensitivity analysis

Sensitivity analysis allows understanding of which variables and assumptions have the most significant impact on the overall modelling results. The scenario modelling used by HW 2025 allows alternative futures to be modelled by varying input parameters. There are two purposes of the alternative scenarios:

  • To explore the implications of possible alternative futures.

  • To demonstrate the sensitivity of the model to various input parameters.

By altering parameters in the model, the flow-through effect to the future workforce can be measured through the impact relative to the comparison scenario. The comparison scenario is a technical construct for modelling purposes, generated to enable the evaluation of the impact that planning scenarios may have on the medical, nursing and midwifery workforces. It should be interpreted as a “do nothing” scenario in which the conditions in 2009 are projected into the future without significant change. In modelling the alternative scenarios, the variables that respond with the most significant change demonstrate the sensitivity of the model to that parameter. This can assist in highlighting which datasets should be a future priority in terms of improving data availability and quality as well as guiding the formulation of other alternative scenarios.

An iterative process

In any modelling, projections become less accurate as the period of time over which they apply increases. This is owing to many factors, including error in projection methodologies, changes in service delivery (eg, technological change) that impact on the relationship between the type and number of services provided, and changes in data and assumptions used in the projections. The World Health Organization noted:

It is therefore critical that plans include mechanisms for adjustment according to changing ongoing circumstances. Making projections is a policy-making necessity, but is also one that must be accompanied by regular re-evaluation and adjustment.8

In recognition of this, HW 2025 is not a one-off project. Projections will be updated annually as new data become available, and the methodology and assumptions will be periodically reviewed with the assistance of clinical experts, to ensure the projections remain realistic and relevant.

Looking forward

One of the key principles underpinning HW 2025 is that it will be an ongoing process in which projections will be continually improved. There are several factors that will be pursued with the aim of improving HW 2025 projections.

Data collection

Modelling relies on the data from which the model’s parameter inputs and base workforce are derived. HW 2025 uses national datasets, the availability of which for the health workforce is limited. In the initial iteration of HW 2025, considerable reliance has been placed on the medical labour force surveys and nursing and midwifery labour force surveys undertaken by the Australian Institute of Health and Welfare. A key future direction is to improve the quality of existing national datasets and identify additional datasets that can be used. In particular, future iterations of HW 2025 are expected to use labour force data from the national registration and accreditation scheme, administered by the Australian Health Practitioner Regulation Agency. A piece of infrastructure being developed by HWA that will support this direction is the National Health Workforce Statistical Resource, incorporating the National Health Workforce Dataset. This will provide a repository of data and integrated tools to assist in health workforce planning by all levels of government and other organisations, as well as by HWA.

Alternative demand measures

The demand for health professionals can vary as a function of changes in population characteristics, changes to expectations of care, new models of care, or workplace changes due to workforce reform that result in an increase or decrease in the relative requirement for certain professions. HWA is currently investigating demand measurement methods that could be used as an alternative to current utilisation.

Consideration of skills or competency-based planning

In Australia, it is recognised that in addition to this form of traditional workforce planning methodology, there is a need to enable planning for the health roles and models of service delivery that will best meet the needs of consumers and be responsive to regional planning requirements.9 In addition to workforce planning, HWA has a focus on workforce innovation and reform to encourage the development of health workforce models to support new models of health care delivery. The workforce modelling tool developed as part of HW 2025 will be able to test and evaluate the likely impact of reform predictions and theories.

Expanding the scope of HW 2025

In 2012, the scope of HW 2025 has expanded to include dentistry and a number of selected allied health professions. This is in addition to the projections for doctors, nurses and midwives being updated as new data become available.

Conclusion

There is an ongoing need for health workforce planning to meet the challenges the Australian health workforce is facing now and in the future. Health workforce projections provide a tool to enable planning by highlighting areas of potential workforce imbalance that may call for government intervention or reform. While health workforce projections have been generated at national and state and territory levels previously, this was often done using different datasets, assumptions and methodologies, making it difficult to provide a nationally coherent view of the future health workforce. Through HW 2025, HWA is developing a set of nationally authoritative, consistent and coherent health workforce projections that can be used for health workforce planning. In particular, the iterative nature of HW 2025 provides a means for planners to monitor the impact of incremental adjustments to the health workforce, taking account of significant changes in the health system or underlying social and economic environment.

Key national sources of data

Workforce group

Data source


Doctors

Workforce headcount and demographics

AIHW Medical Labour Force Survey

Graduates

Medical Deans Australia and New Zealand

Fellows

Medical colleges

Immigration

Department of Immigration and Citizenship

Demand

Hospital separation statistics

Medicare utilisation statistics

Australian and New Zealand Intensive Care Society

Nurses

Workforce headcount and demographics

AIHW Nursing and Midwifery Labour Force Survey

Graduates

Department of Employment, Education and Training
(for registered nurses) and NCVER
(for enrolled nurses)

Immigration

Department of Immigration and Citizenship

Demand

Hospital separation statistics

Community care places

Residential high-care places

Australian and New Zealand Intensive Care Society

Midwives

Workforce headcount and demographics

AIHW Nursing and Midwifery Labour Force Survey

Graduates

Department of Employment, Education and Training

Immigration

Department of Immigration and Citizenship

Demand

ABS Births Australia (ABS Cat. No. 3301.0)

ABS Australian population projections series B

AIHW = Australian Institute of Health and Welfare. NCVER = National Centre for Vocational Education Research. ABS = Australian Bureau of Statistics.

A real-world, data-driven view of general practice prescribing

In my years of working in the health sector, one of the biggest ongoing challenges we are yet to resolve is how to get access to quality population-level data. In this era of progressive health informatics, and despite our incredible advancements in technology, it continues to be a tricky problem.

In 2012, NPS MedicineWise set out to develop a way to better understand prescribing behaviour in Australian general practice — how medicines are prescribed, for whom and why, and what happens when new medicines become available. This program is called MedicineInsight and over 300 practices nationally are now participating, representing over 1500 general practitioners and 3.5 million patient encounters to date.

So how does it work? Using a custom-built data extraction tool that operates seamlessly and securely in the background with the practice’s clinical software, non-identifiable patient and clinical care information from participating practices is collected and analysed. Regular reports and whole-of-practice facilitated discussions assist GPs to track their patient care over time, and in particular their prescribing of medicines. This provides a better understanding of the effect of those medicines on patients and where health care improvements could occur, either in practice or in policy. The program is government-funded and received ethics approval from the Royal Australian College of General Practitioners. Early evaluation indicates that participants greatly value the tailored reports they receive to inform and improve their clinical practice and patient care.

MedicineInsight has the potential to be the primary source of real-world general practice data on patient care, from diagnosis through to medicines used, tests ordered and clinical impacts of management. These unique longitudinal data will inform health services planning, monitoring and evaluation at all levels — from the individual patient to the whole health system. However, realising this potential relies on more practices becoming involved. More information on the program and how to register is available at http://www.medicineinsight.org.au.